New nasal spray could offer Needle-Free migraine relief for kids in ER
NCT ID NCT06083571
Summary
This study tested whether a combination of a nasal spray (ketorolac) and two oral pills could relieve migraine pain as effectively as the standard treatment, which involves an intravenous (IV) drip. It involved 41 children with migraines who came to a pediatric emergency department. The goal was to see if the nasal approach could provide similar pain reduction within 60 minutes, potentially offering a less invasive option.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEADACHE, MIGRAINE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Washington University in St. Louis
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.